{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:21:55Z","timestamp":1791382915529,"version":"4.3.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04181-5","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:47:02Z","timestamp":1751381222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["How serious is the risk of HTLV-1 infection in Iranian hemodialysis-dependent patients?"],"prefix":"10.1186","volume":"26","author":[{"given":"Mahdi","family":"Mohammaditabar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Moien","family":"Forghani-Ramandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niusha","family":"Amirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Saidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sama","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin Fathi","family":"Hafshejani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed-Hamidreza","family":"Mozhgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"12","key":"4181_CR1","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77(12):7415\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8917","key":"4181_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0140-6736(94)93032-5","volume":"344","author":"HF Liu","year":"1994","unstructured":"Liu HF, Vandamme AM, Van Brussel M, Desmyter J, Goubau P. New retroviruses in human and Simian T-lymphotropic viruses. Lancet. 1994;344(8917):265\u20136.","journal-title":"Lancet"},{"issue":"2","key":"4181_CR3","first-page":"85","volume":"7","author":"M Dayyani","year":"2015","unstructured":"Dayyani M, Hedayati-Moghaddam MR, Amini AR. HTLV-1 infection as a serious health issue among Iranian multi-transfused patients: Evidence from a systematic review and meta-analysis. Iran J Blood Cancer. 2015;7(2):85\u201394.","journal-title":"Iran J Blood Cancer"},{"issue":"39","key":"4181_CR4","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","volume":"24","author":"FA Proietti","year":"2005","unstructured":"Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058\u201368.","journal-title":"Oncogene"},{"issue":"3","key":"4181_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/infdis\/162.3.649","volume":"162","author":"R Yanagihara","year":"1990","unstructured":"Yanagihara R, Jenkins CL, Alexander SS, Mora CA, Garruto RM. Human T lymphotropic virus type I infection in Papua new Guinea: high prevalence among the Hagahai confirmed by Western analysis. J Infect Dis. 1990;162(3):649\u201354.","journal-title":"J Infect Dis"},{"issue":"3","key":"4181_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcv.2011.07.004","volume":"52","author":"H Rafatpanah","year":"2011","unstructured":"Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: A population-based seroepidemiology survey. J Clin Virol. 2011;52(3):172\u20136.","journal-title":"J Clin Virol"},{"issue":"2","key":"4181_CR7","first-page":"124","volume":"7","author":"R Hekmat","year":"2013","unstructured":"Hekmat R, Gholami F, Ahmadnia H, Ahmadi M, Hassannia T. Serum human T-lymphotropic virus 1 proviral load in patients on Hemodialysis. Iran J Kidney Dis. 2013;7(2):124\u20138.","journal-title":"Iran J Kidney Dis"},{"issue":"2","key":"4181_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000185295","volume":"51","author":"T Uematsu","year":"1989","unstructured":"Uematsu T, Hanada S, Saito T, Otsuka M, Komidori K, Osaki K, et al. Adult T cell leukemia in Hemodialysis patients from the Kagoshima district, an area in which human T cell leukemia virus type I is highly endemic. Nephron. 1989;51(2):257\u201360.","journal-title":"Nephron"},{"issue":"3","key":"4181_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0272-6386(88)80120-3","volume":"12","author":"K Morikawa","year":"1988","unstructured":"Morikawa K, Kuroda M, Tofuku Y, Uehara H, Akizawa T, Kitaoka T, et al. Prevalence of HTLV-1 antibodies in Hemodialysis patients in Japan. Am J Kidney Dis. 1988;12(3):185\u201393.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"4181_CR10","first-page":"259","volume":"39","author":"A Karimi","year":"2007","unstructured":"Karimi A, Nafici M, Imani R. Comparison of human T-cell leukemia virus type-1 (HTLV-1) Seroprevalence in high risk patients (thalassemia and hemodialysis) and healthy individuals from Charmahal-Bakhtiari Province, Iran. Kuwait Med J. 2007;39(3):259.","journal-title":"Kuwait Med J"},{"issue":"2","key":"4181_CR11","first-page":"44","volume":"6","author":"A Karimi","year":"2023","unstructured":"Karimi A, Nafisi M. Seroprevalence of human T-cell leukemia virus type-1 (HTLV-1) in high risk patients. J Res Health Sci. 2023;6(2):44\u20137.","journal-title":"J Res Health Sci"},{"issue":"6","key":"4181_CR12","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3747\/pdi.2012.00054","volume":"34","author":"I Najafi","year":"2014","unstructured":"Najafi I, Alatab S, Atabak S, Majelan NN, Sanadgol H, Makhdoomi K, et al. Seventeen years\u2019 experience of peritoneal dialysis in Iran: first official report of the Iranian peritoneal dialysis registry. Perit Dial Int. 2014;34(6):636\u201342.","journal-title":"Perit Dial Int"},{"issue":"7","key":"4181_CR13","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.3390\/ijerph18073471","volume":"18","author":"H-J Lee","year":"2021","unstructured":"Lee H-J, Son Y-J. Prevalence and associated factors of frailty and mortality in patients with End-Stage renal disease undergoing hemodialysis: A systematic review and Meta-Analysis. Int J Environ Res Public Health. 2021;18(7):3471.","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"4181_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.34172\/aim.2020.68","volume":"23","author":"S Taherpour","year":"2020","unstructured":"Taherpour S, Javanmard D, Ziaee M. Occult hepatitis C virus infection among Hemodialysis patients: an Iranian experience. Arch Iran Med. 2020;23(9):586\u201392.","journal-title":"Arch Iran Med"},{"issue":"2","key":"4181_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2215\/CJN.05260516","volume":"12","author":"M Saha","year":"2017","unstructured":"Saha M, Allon M, Diagnosis. Treatment, and prevention of Hemodialysis emergencies. Clin J Am Soc Nephrol. 2017;12(2):357\u201369.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"4181_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.ajkd.2020.02.441","volume":"76","author":"S Waheed","year":"2020","unstructured":"Waheed S, Philipneri M. Targeting zero infections in the outpatient Dialysis unit: core curriculum 2020. Am J Kidney Dis. 2020;76(1):130\u201340.","journal-title":"Am J Kidney Dis"},{"key":"4181_CR17","unstructured":"https:\/\/idiasys.com\/en\/dialysis-stats\/?utm_source=chatgpt.com."},{"key":"4181_CR18","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372:n71.","DOI":"10.1136\/bmj.n71"},{"key":"4181_CR19","doi-asserted-by":"crossref","unstructured":"Ma L-L, Wang Y-Y, Yang Z-H, Huang D, Weng H, Zeng X-T. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res. 2020;7(1):7.","DOI":"10.1186\/s40779-020-00238-8"},{"key":"4181_CR20","doi-asserted-by":"crossref","unstructured":"Yazdani R, Dadmanesh M, Ghorban K. First report of the prevalence of human T-lymphotropic virus type 1 (HTLV-1) for hemodialysis patients in Tehran. Arch Clin Infect Dis. 2018;13(4).","DOI":"10.5812\/archcid.65512"},{"key":"4181_CR21","unstructured":"Pourkarim M, Khamisipour G, Hajiani G, Tahmasebi R, Ardeshirdavani N. Seroepidemiological investigation of HTLV I, II infection among Busherian multi-transfused patients in 2003. Sci J Iran Blood Transfus Organ. 2005;2(4):99\u2013104."},{"key":"4181_CR22","unstructured":"Hedayati-Moghaddam MR, Fathimoghadam F, Soghandi L, Darrudi A. High prevalence of HTLV-1 infection among hemodialysis patients in Ney shabur, Northeast of Iran: a clinical trial. Int J Infect (in press)."},{"key":"4181_CR23","doi-asserted-by":"crossref","unstructured":"Ziaee M, Azizee R, Namaei MH. Prevalence of HCV infection in hemodialysis patients of South Khorasan in comparison With HBV, HDV, HTLV I\/II, And HIV infection. Bangladesh J Med Sci. 2014;13(1):36.","DOI":"10.3329\/bjms.v13i1.13903"},{"key":"4181_CR24","unstructured":"Khameneh ZR, Baradaran M, Sepehrvand N. Survey of the seroprovalence of HTLV I\/II in hemodialysis patients and blood donors in Urmia. Saudi J Kidney Dis Transpl. 2008;19(5):838\u201341."},{"key":"4181_CR25","unstructured":"Ghaffari J, Ebrahimi M, Makhlough A, Mohammadjafari H, Nazari Z. Seroepidemiology of human T-cell lymphotropic virus 1 infection in hemodialysis patients: should we be concerned about it? Iran J Kidney Dis. 2013;7(3):187."},{"key":"4181_CR26","unstructured":"Ardalan N, Abdi M, Zarif BR, Amini A, Memary F, Haydari E, et al. Prevalence of human T-lymphotropicvirus types I&II among high risk groups in Sanandaj in 2010. Sci J Kurdistan Univ Med Sci. 2013;18(2)."},{"issue":"3","key":"4181_CR27","doi-asserted-by":"publisher","first-page":"e14920","DOI":"10.5812\/jjm.14920","volume":"8","author":"S Ahmadi Ghezeldasht","year":"2015","unstructured":"Ahmadi Ghezeldasht S, Hassannia T, Rafatpanah H, Hekmat R, Valizadeh N, Ghayour Mobarhan M, et al. Oncogenic virus infections in the general population and End-stage renal disease patients with special emphasis on Kaposi\u2019s sarcoma associated herpes virus (KSHV) in Northeast of Iran. Jundishapur J Microbiol. 2015;8(3):e14920.","journal-title":"Jundishapur J Microbiol"},{"key":"4181_CR28","unstructured":"Karimi A, Nafisi M. Seroprevalence of human T-cell leukemia virus Type-1 (HTLV-1) in high risk patients. J Res Health Sci. 2011."},{"key":"4181_CR29","unstructured":"Abedi F, Yavarian M, Shakibzadeh A, Khalvati B, Asadi A. A pilot Seroepidemiologic study of HTLV in thalassemia, hemophilia, and hemodialysed patients in Hormozgan. HMJ. 2009;13(2):75\u201380."},{"key":"4181_CR30","unstructured":"Zabetian H, Jahromi AS, Yousefi A, Haghshenas F, Farhadi S, Vasmehjani AA, et al. Prevalence of human T-lymphotropic virus among high risk patients: a cross-sectional study in Jahrom, Southern, Iran."},{"key":"4181_CR31","doi-asserted-by":"crossref","unstructured":"Hatatian F, Babakhani F, Gudarzi H, Momenifar N, Norouzi M, Shafieifar M, et al. Relative frequency of blood-borne viruses in hemodialysis-dependent and kidney transplant recipients in iran. Iran J Public Health. 2020;49(11):2136.","DOI":"10.18502\/ijph.v49i11.4731"},{"key":"4181_CR32","unstructured":"Karimi A, Nafisi M. Seroprevalence of human T-cell leukemia virus type-1 (HTLV-1) in high risk patients. J Res Health Sci. 2006;6(2):44\u20137."},{"key":"4181_CR33","doi-asserted-by":"crossref","unstructured":"Hedayati-Moghaddam MR, Fathimoghadam F, Soghandi L, Darrudi A. High prevalence of HTLV-1 infection among Hemodialysis patients in Neyshabur, Northeast of Iran. Int J Infect. 2019;6(1):e85164.","DOI":"10.5812\/iji.85164"},{"key":"4181_CR34","doi-asserted-by":"crossref","unstructured":"Perez G, Ortiz-Interian C, Lee H, de Medina M, Cerney M, Allain JP, et al. Human immunodeficiency virus and human T-cell leukemia virus type I in patients undergoing maintenance hemodialysis in Miami. Am J Kidney Dis. 1989;14(1):39\u201343.","DOI":"10.1016\/S0272-6386(89)80091-5"},{"key":"4181_CR35","unstructured":"Wyatt CM. The kidney in HIV infection: beyond HIV-associated nephropathy. Top Antivir Med. 2012;20(3):106\u201310."},{"key":"4181_CR36","doi-asserted-by":"crossref","unstructured":"Khorrami MB, Amali A, Sadeghi M, Riahi-Zanjani B. The prevalence of HBV, HCV, and HIV among hemodialysis patients in a tertiary care hospital in Mashhad, Iran. J Infect Dev Ctries. 2023;17(8):1146\u201351.","DOI":"10.3855\/jidc.16874"},{"key":"4181_CR37","doi-asserted-by":"crossref","unstructured":"Ortiz C, Meneses R, Jaffe D, Fernandez JA, Perez G, Bourgoignie JJ. Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. Kidney Int. 1988;34(2):248\u201353.","DOI":"10.1038\/ki.1988.172"},{"key":"4181_CR38","doi-asserted-by":"crossref","unstructured":"Chirgwin K, Rao TK, Landesman SH. HIV infection in a high prevalence hemodialysis unit. Aids. 1989;3(11):731\u20135.","DOI":"10.1097\/00002030-198911000-00007"},{"key":"4181_CR39","doi-asserted-by":"crossref","unstructured":"Lodhi A, Sajjad A, Mehmood K, Lodhi A, Rizwan S, Ubaid A, et al. Profile and predictors of hepatitis and HIV infection in patients on hemodialysis of Quetta, Pakistan. Drug Discov Ther. 2019;13(5):274\u20139.","DOI":"10.5582\/ddt.2019.01044"},{"key":"4181_CR40","doi-asserted-by":"crossref","unstructured":"Dayyani M, Hedayati-moghaddam Mr, Ar A. HTLV-1 infection as a serious health issue among Iranian multi-transfused patients: Evidence from a systematic review and meta-analysis. Iran J Blood Cancer. 2015;7.","DOI":"10.3390\/v7112904"},{"issue":"1","key":"4181_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12882-017-0484-y","volume":"18","author":"RF Santos","year":"2017","unstructured":"Santos RF, Concei\u00e7\u00e3o GC, Martins MS, Kraychete A, Penalva MA, Carvalho EM, et al. Prevalence and risk factors for human T-Lymphotropic virus type 1 (HTLV-1) among maintenance Hemodialysis patients. BMC Nephrol. 2017;18(1):64.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4181_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1492-7535.2004.0085bh.x","volume":"8","author":"I Stefanidis","year":"2004","unstructured":"Stefanidis I, Zervou E, Rizos C, Liaskos C, Zarogiannis S, Liakopoulos V, et al. Prevalence of hepatitis (A\u2013E) and HTLV-I\/II infection markers in Hemodialysis patients of central Greece. Hemodial Int. 2004;8(1):101.","journal-title":"Hemodial Int"},{"issue":"3","key":"4181_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0928-0197(94)90018-3","volume":"2","author":"HH Lee","year":"1994","unstructured":"Lee HH, Galli C, Burczak JD, Biffoni F, De Stasio G, De Virgiliis S, et al. A multicentric seroepidemiological survey of HTLV-I\/II in Italy. Clin Diagn Virol. 1994;2(3):139\u201347.","journal-title":"Clin Diagn Virol"},{"key":"4181_CR44","doi-asserted-by":"crossref","unstructured":"Azami M, Badfar G, Esmaeli E, Moslemirad M, Rahmati S. Epidemiology of human T-lymphotropic virus type 1 among blood donors and general population in Iran: a meta-analysis. Future Virol. 2018;13(8):585\u201399.","DOI":"10.2217\/fvl-2018-0015"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04181-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04181-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04181-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:47:10Z","timestamp":1751381230000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04181-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4181"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04181-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of Alborz University of Medical Sciences approved this study (IR.ABZUMS.REC.1401.328).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"340"}}